Atlas Trials

Hypertension and Dyslipidemia

15 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Hypertension and Dyslipidemia

RecordFirmDate
Study to Evaluate the Safety and Pharmacokinetics of CKD-331 (NCT05335044)Chong Kun Dang Pharmaceutical2022-05-31
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg (NCT05245084)Chong Kun Dang Pharmaceutical2022-03-15
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3) (NCT05192356)Chong Kun Dang Pharmaceutical2022-02-23
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) 80/20/10mg (NCT04987970)Chong Kun Dang Pharmaceutical2021-09-12
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(2) (NCT04883658)Chong Kun Dang Pharmaceutical2021-06-04
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(2) (NCT04694989)Chong Kun Dang Pharmaceutical2021-02-20
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386 (NCT04673864)Chong Kun Dang Pharmaceutical2021-01-17
A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348 (NCT04660370)Chong Kun Dang Pharmaceutical2021-01-09
A Clinical Trial to Evaluate the Pharmacokinetics and Tolerability of CKD-348 (NCT04587206)Chong Kun Dang Pharmaceutical2020-10-15
A Combination Drug Including Fimasartan and Statins in Patients With Hypertension and Dyslipidemia (NCT04554953)Boryung Pharmaceutical Co., Ltd2020-04-13
Study of Multiple Oral Dosing to Evaluate the Safety and the Pharmacokinetic Drug-drug Interaction of Telmisartan/Amlodipine and Rosuvastatin in Healthy Male Volunteers (NCT02933658)Daewon Pharmaceutical Co., Ltd.2015-11-01

Track Hypertension and Dyslipidemia automatically

Every clearance here is in the API, with alerts when new ones post.